Article

RAGE antagonist peptide mitigates AGE-mediated endothelial hyperpermeability and…

medRxiv · 2021 · Camillo, C.; Abramov, A.; Allen, P. M.; Castillero, E.; Roberts, E.; Xue, Y.; Frasca, A.; Moreno, V.; Kurade, M.; Robinson, K.; Spiegel, D.; LaPar, D.; Grau, J. B.; Assoian, R.; Bavaria, J. E.; Takayama, H.; Ferrari, G.

Key facts

Title RAGE antagonist peptide mitigates AGE-mediated endothelial hyperpermeability and accumulation of glycoxidation products in human ascending aortas and in a murine model of aortic aneurysm
First author Camillo, C.; Abramov, A.; Allen, P. M.; Castillero, E.; Roberts, E.; Xue, Y.; Frasca, A.; Moreno, V.; Kurade, M.; Robinson, K.; Spiegel, D.; LaPar, D.; Grau, J. B.; Assoian, R.; Bavaria, J. E.; Takayama, H.; Ferrari, G.
Journal medRxiv
Published Oct 24, 2021
DOI 10.1101/2021.10.22.465199
Devices mentioned K042884, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 4 more
Product codes mentioned CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, JLX, KLB and 12 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature